Controversies in Drug Allergy: Radiographic Contrast Media Mario Sánchez-Borges, MD, Werner Aberer, MD, Knut Brockow, MD, Gulfem E. Celik, MD, Josefina Cernadas, MD, Paul A. Greenberger, MD, Marie-Soleil Masse, MD, Rik Schrijvers, MD, Axel Trautmann, MD The Journal of Allergy and Clinical Immunology: In Practice Volume 7, Issue 1, Pages 61-65 (January 2019) DOI: 10.1016/j.jaip.2018.06.030 Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Figure 1 Mechanisms of hypersensitivity reactions to radiocontrast media. RCM, Radiocontrast media. The Journal of Allergy and Clinical Immunology: In Practice 2019 7, 61-65DOI: (10.1016/j.jaip.2018.06.030) Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Figure 2 Skin test–based management of patients with immediate reactions to radiocontrast media. DPT, Drug provocation test; RCM, radiocontrast media. The Journal of Allergy and Clinical Immunology: In Practice 2019 7, 61-65DOI: (10.1016/j.jaip.2018.06.030) Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Figure 3 Skin test–based management of patients with nonimmediate reactions to radiocontrast media (RCM). RCM are contraindicated in patients with Stevens-Johnson syndrome, toxic epidermal necrolysis, or DRESS. DRESS, Drug reaction with eosinophilia and systemic symptoms. The Journal of Allergy and Clinical Immunology: In Practice 2019 7, 61-65DOI: (10.1016/j.jaip.2018.06.030) Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions